XTL Biopharma (XTLB) Reports Q1 Loss of $0.01/Share

XTL Biopharma (NASDAQ: XTLB) reported Q1 EPS of ($0.01), versus $0.00 reported last year.

For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Rithm Capital Corp. (RITM) PT Lowered to $14 at UBS on Higher for Longer Rates
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance